We use cookies and similar technologies to run this website. See Terms and Conditions.

Online education for healthcare professionals
Physician's chats
Pharmacist's chats
Register
Access to free materials

Pharmacology of diuretics

Pharmacology of diuretics
Published Wednesday 14 December 2022

Classification and application points of the most commonly used diuretics

Published by: Diana Luai Awad, Dr Pharmacist on Wednesday 14. December 2022

Diuretics are one of the most important drugs in clinical practice, which have been used for over 50 years in the treatment of a number of diseases. Although they all act by altering the reabsorption of sodium in the renal tubules, diuretics differ in their mechanism of action and have different pharmacological properties and indications.

Anatomy and physiology of the urinary system

Before describing the mechanisms of action of diuretics, it is appropriate to refresh one's memory of the structure and functioning of the kidneys. The main urine-forming unit of the kidney is the nephron: each kidney consists of 1 million nephrons. These, in turn, include Bowman's capsule, convoluted tubules, and the loop of Henle. 

  • In the capsule plasma is filtered, as a result, coarse proteins and blood cells are retained, and the filtered primary urine enters the tubules1.
  • In the proximal part of the convoluted tubules, sodium (most of it), bicarbonates, chlorine and water are reabsorbed, and protons are secreted into the lumen of the tubules.
  • The descending part of the loop of Henle is permeable only to water: according to the law of osmosis, water moves in a hyperosmolar direction and is reabsorbed. 
  • In the thick segment of the ascending loop of Henle, sodium, potassium, chlorides, as well as magnesium and calcium are reabsorbed.
  • In the distal part of the convoluted tubules, a small amount of chlorine, calcium (regulated by parathyroid hormone), sodium is also reabsorbed in exchange for the excretion of potassium into the urine (the regulator is aldosterone).

Water is reabsorbed in the collecting ducts under the action of antidiuretic hormone.

Figure 1. The basic structure of the nephron and the main points of application of diuretics

CAI, carbonic anhydrase inhibitors; LD, loop diuretics; TD, thiazide diuretics; SP, aldosterone anatagonists; VP, vaptans; ADH, antidiuretic hormone.

Table. Reabsorbent and secretory functions of various segments of the renal tubules1

Tubular segment

Filtered load reabsorbed or secreted, %

Tubular osmolality compared with plasma

Na+

Urea

Water

Proximal tubule

65

50 absorbed

65

Isosmotic due to simultaneous

Na+ and water reabsorption

Descending thin limb

of Henle loop

0

50 secreted

10

Isosmotic. No significant

reabsorption

Ascending thin and thick

limbs of Henle loop

25

0

0

Hypoosmotic due to active

Na+ reabsorption

Distal tubule

5

0

0

Hypoosmotic due to active

Na+ reabsorption

Collecting duct system

4-5

50 absorbed

(5–24) depending

on the level

of ADH

Hyper/hypo/isosmotic depending

on ADH influence and medullary

hypertonicity

 

Classification of diuretics by mechanism of action

There are several classifications of diuretics, but one of the most famous and frequently used in practice is this classification1-3:

  • Carbonic anhydrase inhibitors block the function of carbonic anhydrase within the brush border and within the epithelial cells of the proximal tubules; main purpose is the treatment of glaucoma1,2
    Acetozolamide, dorzolamide, brinzolamide
  • Loop diuretics inhibit the Na+-K+-2Cl cotransporter (NKCC) in the thick ascending loop of Henle and are successfully used in patients with edema in chronic kidney disease and arterial hypertension1,2
    Furosemide, torasemide, ethacrynic acid
  • Thiazide and thiazide-like diuretics inhibit an electroneutral NaCl co-transport pathway at the distal convoluted tubule and represent the cornerstone of antihypertensive therapy for many years1,2
    Hydrochlorothiazide, indapamide
  • Potassium-sparing diuretics
  • Epithelial sodium channel blocking agent inhibit the epithelial Na+ channel in the collecting duct and are mainly used in the treatment of hypertension in combination with other diuretics to correct potassium deficiency in patients without mineralocorticoid excess1,2 

Triamterene, amiloride

  • Aldosterone antagonists block the aldosterone mineralocorticoid receptors in the cytoplasm of principal cells of the collecting duct. Aldosterone antagonists are traditionally used for primary aldosteronism, but recent evidence indicates that they reduce morbidity and mortality in patients with heart failure1,2

Spironolactone, eplerenone

  • Osmotic diuretics exerts an osmotic effect along the renal tubule, inhibiting water and solute reabsorption without interfering with tubular electrolyte transport systems and is widely used for treatment of cerebral oedema1,2
    Mannitol.

Application points, mechanism of action, indications, side effects of the most commonly used diuretics1-4

Class1

Site of action

Enzyme/channel inhibited

Clinical uses

Side effects

Carbonic anhydrase inhibitors

Proximal segment:

acetazolamide,

brinzolamide,

dorzolamide, and

methazolamide

Carbonic anhydrase

inhibition causes acute

sodium bicarbonate

diuresis

Glaucoma, metabolic

alkalosis due to loop

diuretics, acute

mountain sickness,

hyperphosphatemia,

and urinary

alkalinization

Hyperchloremic metabolic

acidosis, hypophosphatemia,

renal stones, and

hypokalemia

Loop diuretics

Loop of Henle:

furosemide,

bumetanide,

torasemide, and

ethacrynic acid

Active Na+–K+–2Cl2

carrier. Mutation

of this carrier

results in

decreased Na+

reabsorption—eg,

Bartter syndrome

Acute pulmonary edema,

congestive

heart failure (CHF), hypercalcemia,

hyperkalemia,

and syndrome of inappropriate

ADH (antidiuretic hormone) secretion (SIADH)

Metabolic alkalosis,

hypomagnesemia,

hypocalcemia (only in

hypoparathyroid patients),

hypokalemia, hyperuricemia,

and ototoxicity

Thiazide diuretics

Distal tubule:

thiazides— hydrochlorothiazide,

indapamide,

chlorthalidone,

and metolazone

Active Na+–Cl2 carrier.

Mutation of this carrier

results in decreased

Na+ absorption—eg,

Gitelman syndrome

Hypertension, idiopathic

hypercalciuria, and

nephrogenic diabetes insipidus

Metabolic alkalosis,

hypercalcemia, hypokalemia,

hyperuricemia, hyperlipidemia,

hyponatremia, hyperglycemia,

and impotence

Potassium-sparing diuretics

Connecting segment

and collecting tubule:

aldosterone

antagonists

(spironolactone,

eplerenone),

amiloride, and

triamterene

Gradient related Na+

channel. Mutation

of this channel results

in increased Na+

reabsorption—eg,

Liddle syndrom

Spironolactone—primary

and secondary

hyperaldosteronism,

CHF, and

hyperandrogen

states 

Amiloride—Bartter syndrome, Liddle syndrome,

and nephrogenic diabetes insipidus

Hyperchloremic metabolic

acidosis, hyperkalemia,

gynecomastia, and

antiandrogen effects

(with spironolactone).

Nephrolithiasis, acute renal failure (with triamterene)

Osmotic diuretics

Multiple parts of nephron:

eg, mannitol

Inhibit water

reabsorption in

proximal tubule,

descending

loop of Henle,

and collecting

tubules

Intracranial hypertension,

prevention of renal

failure after large

pigment loads,

dialysis disequilibrium

syndrome, barbiturate

intoxication

Hyponatremia, CHF,

hypernatremia with

chronic use

 

Bibliography

  1. Reddy P., Mooradian A. D. Diuretics: an update on the pharmacology and clinical uses //American journal of therapeutics.2009; 16 (1): 74-85.
  2. Brater D. C. Pharmacology of diuretics //The American journal of the medical sciences. 2000; 319 (1): 38-50.
  3. Sarafidis P. A., Georgianos P. I., Lasaridis A. N. Diuretics in clinical practice. Part I: mechanisms of action, pharmacological effects and clinical indications of diuretic compounds //Expert opinion on drug safety. 2010; 9 (2): 243-257.
  4. Roush G. C., Kaur R., Ernst M. E. Diuretics: a review and update //Journal of cardiovascular pharmacology and therapeutics. 2014; 19 (1): 5-13.

 

Colleagues, haven't you joined our PharmaCourses of MENA region Telegram chats yet?

In the chats of more than 6,000 participants, you can always discuss breaking news and difficult situations in a pharmacy or clinic with your colleagues. Places in the chats are limited, hurry up to get there.

Telegram chat for pharmacists of MENA region: https://t.me/joinchat/V1F38sTkrGnz8qHe 

Telegram chat fo physicians of MENA region: https://t.me/joinchat/v_RlWGJw7LBhNGY0

Last article
Pharmacology of diuretics
14 December

Pharmacology of diuretics

Classification and application points of the most commonly used diuretics

Tricyclic Antidepressants in Modern Medicine
29 November

Tricyclic Antidepressants in Modern Medicine

Mechanism of action and indications for the use of TCAs

Sports, stress and yogurts: facts and myths about immunity
22 November

Sports, stress and yogurts: facts and myths about immunity

Nine interesting facts about the human immune system

Most popular
Pharmacology of diuretics
14 December

Pharmacology of diuretics

Classification and application points of the most commonly used diuretics

Tricyclic Antidepressants in Modern Medicine
29 November

Tricyclic Antidepressants in Modern Medicine

Mechanism of action and indications for the use of TCAs

Sports, stress and yogurts: facts and myths about immunity
22 November

Sports, stress and yogurts: facts and myths about immunity

Nine interesting facts about the human immune system

Latest news
UAE MoHAP, Alhosn App bag the Bronze Stevie Award 2022 for Most Valuable Government Response in COVID-19 Response categories
03 November

UAE MoHAP, Alhosn App bag the Bronze Stevie Award 2022 for Most Valuable Government Response in COVID-19 Response categories

The honor has been given in recognition effectiveness in curbing the COVID-19 pandemic within the UAE

The 5th Saudi Healthcare Simulation Conference 2022, on Nov. 6
03 November

The 5th Saudi Healthcare Simulation Conference 2022, on Nov. 6

The conference will be held under the slogan "Simulation of healthcare to the fullest extent"

Qatar MOPH Supports FIFA World Cup Qatar 2022 to Ensure Food Safety​​
03 November

Qatar MOPH Supports FIFA World Cup Qatar 2022 to Ensure Food Safety​​

MOPH will use best practices during the FIFA World Cup Qatar 2022

Fill in this field

Fill in this field

Fill in this field

Fill in this field

Fill in this field

Fill in this field

Fill in this field

Fill in this field

Please enter the valid phone number

Fill in this field